BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS
    37.
    发明申请
    BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS 审中-公开
    苯并呋喃类化合物在植物体内的生物发生

    公开(公告)号:US20150291517A1

    公开(公告)日:2015-10-15

    申请号:US14647717

    申请日:2012-11-28

    IPC分类号: C07C311/21 A01H4/00

    摘要: Benzenesulfonamide compounds potentiate 2,4-D induced embryogenesis in plants. In particular, 4-chloro-N-methyl-N-(2-methylphenyl)benzenesulfonamide and analogs induce somatic embryogenesis in plants. Methods of inducing somatic embryogenesis comprise exposing selected plant tissues, e.g. seed embryos, to auxins, e.g. 2.4-D and the benzenesulfonamide compounds. Compounds can be prepared by reacting sulfonyl chloride, an amine and pyridine in CH2CI2. Crude product is suspended in ethyl acetate and washed in sodium and potassium hydrogen sulphates and brine, then dried and filtered.

    摘要翻译: 苯磺酰胺化合物增强植物中2,4-D诱导的胚胎发生。 特别地,4-氯-N-甲基-N-(2-甲基苯基)苯磺酰胺和类似物在植物中诱导体细胞胚发生。 诱导体细胞胚发生的方法包括将所选择的植物组织,例如, 种子胚,到生长素,例如 2.4-D和苯磺酰胺化合物。 化合物可以通过使磺酰氯,胺和吡啶在CH 2 Cl 2中反应来制备。 将粗产物悬浮于乙酸乙酯中,并在硫酸钠和氢氧化钾和盐水中洗涤,然后干燥并过滤。

    Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system
    39.
    发明授权
    Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system 失效
    Hh信号级联的杂环抑制剂,基于其的医药组合物和用于治疗由Hh信号系统的异常活性引起的疾病的方法

    公开(公告)号:US08486945B2

    公开(公告)日:2013-07-16

    申请号:US12808152

    申请日:2008-12-12

    摘要: The invention relates to novel heterocyclic compounds and to the use thereof, to pharmaceutical compositions containing said chemical compounds as an active ingredient and to the use thereof for producing medicinal preparations for the human being and warm-blood animals for treating diseases caused by the aberrant activity of an Hedgehog (Hh)-signal system, in particular oncological diseases. The invention also relates to the use of the above-mentioned compounds in the form of ‘molecular pharmacological tools’ for examining (in vitro and in vivo) the biochemical features of the Hh-signal system, in particular, the interaction of Hh protein and transmembrane proteins, namely, suppressor Patched (Ptc) and protooncogenic proteins. The eight groups of the claimed compounds comprise the derivatives of 2,6-dihydro-7H-pyrazolo[3,4-d]pyridazine-7-one and 1,4-dihydropyrazolo[3,4-b][1,4]thiazine-5-one; N-acidylated 4-imidazo[1,2-a]pyrimidine-2-il-anilines; ([4H-thino[3,2-b]pyrrol-5-il) carbonyl]piperidine-4-carbonic acid amides; 2-(4carbomoilpyperidine-1-il)-isonicotinic acid amides; N-sylphonyl-1,2,3,4-tetrahydroquinoline-6-carbonic acid amides; and pyridine 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]N-acidylated 3-azole derivatives.

    摘要翻译: 本发明涉及新颖的杂环化合物及其用途,含有所述化合物作为活性成分的药物组合物及其用于生产用于治疗由异常活性引起的疾病的人和温血动物的药物制剂的用途 刺猬(Hh) - 信号系统,特别是肿瘤疾病。 本发明还涉及以“分子药理学工具”形式的上述化合物用于检查(体外和体内)Hh信号系统的生化特征的用途,特别是Hh蛋白和 跨膜蛋白,即抑制剂Patched(Ptc)和原癌蛋白。 所要求保护的八个化合物组包括2,6-二氢-7H-吡唑并[3,4-d]哒嗪-7-酮和1,4-二氢吡唑并[3,4-b] [1,4] 噻嗪-5-酮; N-酸化的4-咪唑并[1,2-a]嘧啶-2-基]苯胺; ([4H-噻吩并[3,2-b]吡咯-5-基)羰基]哌啶-4-碳酸酰胺; 2-(4-氰基吡啶-1-基) - 异烟酰胺; N-磺酰基-1,2,3,4-四氢喹啉-6-碳酸酰胺; 和吡啶2-氨基-4,5,6,7-四氢噻吩并[2,3-c] N-酸化的3-唑衍生物。